IT'S OVER! THIS VACCINE LAWSUIT CHANGES EVERYTHING

Story by Robert Mendick, Investigations team
The Oxford-AstraZeneca Covid-19 vaccine has been branded “defective” in a multi-million pound landmark legal action that will suggest claims over its efficacy were “vastly overstated”.Show more

The pharmaceutical giant is being sued in the High Court in a test case by Jamie Scott, a father-of-two who suffered a significant permanent brain injury that has left him unable to work as a result of a blood clot after receiving the jab in April 2021. A second claim is being brought by the widower and two young children of 35-year-old Alpa Tailor, who died after having the jab made by AstraZeneca, the UK-based pharmaceutical giant.

The test cases could pave the way for as many as 80 damages claims worth an estimated £80 million over a new condition known as Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT) that was identified by specialists in the wake of the AstraZeneca Covid-19 vaccine rollout.

Last year, the World Health Organisation said the vaccine was “safe and effective for all individuals aged 18 and above” and that the adverse effect that has prompted the legal action was “very rare”. (not rare anymore!)

The vaccine, which was heralded at its launch by Boris Johnson as a “triumph for British science”, is NO longer used in the UK. The Government recommends three other vaccines for its autumn booster programme. (Stay far away from them too!)

In the months following the rollout, the potential serious side effect of the AstraZeneca jab was identified by scientists. Following this, it was recommend it no longer be given to the under-40s in the UK because the risk of receiving the jab outweighed the harm posed by Covid.

AstraZeneca last night told the Telegraph that patient safety was its “highest priority”, that its vaccine, called Vaxzevria, had “continuously been shown to have an acceptable safety profile”, and that regulators around the world “consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects”.
It is understood AstraZeneca, in its legal response, denies causing Mr Scott’s injuries.

Official figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show at least 81 deaths in the UK are suspected to have been linked to the adverse reaction that caused clotting in people who also had low blood platelets. In total, almost one in five people who suffered from the condition died as a result, according to the MHRA’s own figures.
The case will raise questions about what the UK authorities KNEW about concerns over the vaccine and how they were handled.

An examination of WhatsApp messages sent by or to Matt Hancock, the then health secretary, obtained by The Telegraph as part of the Lockdown Files and which have been passed to the Covid public inquiry, suggest concerns were aired by US authorities. AstraZeneca NEVER in the end applied for a licence in the US.

At the time, a number of European countries were pausing the vaccine’s rollout over fears it caused clotting in some people.
In Mr Scott’s claim, his lawyers argue that he suffered “personal injuries and consequential losses arising out of his sustaining Vaccine Induced Immune Thrombosis with Thrombocytopenia (VITT) as a result of his vaccination on 23 April 2021, with the AstraZeneca Covid-19 vaccination”, which the legal claim alleges was “defective”. They also argue that no warning of the risk of VITT was included in the product information on the date of supply of the vaccine.

The Astrazeneca vaccine was suspended in Canada in 2021 for people under age 55. (They should have suspended ALL THE VACCINES for all ages at that time).

Full story:
https://www.msn.com/en-us/health/other/oxford-astrazeneca-covid-jab-was-defective-claims-landmark-legal-case/ar-AA1jBqHn